About Skanray Technologies Limited
Data last updated: 13 March 2026
Skanray Technologies Limited is a public limited company based in Mysore, Karnataka, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 14 February 2007, the company has been in operation for over 19 years.
Registered with ROC Bangalore under CIN U72200KA2007PTC041774.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹44.11 Cr. Formerly known as Skanray Technologies Private Limited. It is led by directors including Doddaballapur Prasanna Achutarao and Vishwaprasad Alva.
Last AGM: 30 October 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 15 – 17 Hebbal Industrial Area, Mysore, Karnataka, India – 570016.
As per the financials filed for FY 2025, the company reported a revenue of ₹213.3 Cr, a decline of 22% compared to the previous year.
The company has a workforce of approximately 626 employees as per the latest available data.
The company is associated with 3 brands - Skanray Americas, Skanray Healthcare, Skanray. As per MCA filings, the company has open charges of ₹181.39 Cr and satisfied charges of ₹184.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website skanray.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressPlot No 15 – 17 Hebbal Industrial Area, Mysore, Karnataka, India – 570016
-
IndustryHealthcare, Medical & Laboratory Equipment, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Skanray Technologies Limited
Skanray Technologies Limited has one previous CIN (Corporate Identification Number): U72200KA2007PTC041774. The current CIN is U72200KA2007PLC041774, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200KA2007PLC041774 | Current |
| U72200KA2007PTC041774 | Previous |
Associated Brands with Skanray Technologies Limited
Skanray Technologies Limited operates multiple associated brands including Skanray Americas, Skanray Healthcare, and Skanray. These brands represent Skanray Technologies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Developer of a wide range of monitoring systems | skanrayhealthcare.com | |
| R&D company focused on manufacturing diagnostic devices for multiple therapeutic areas | skanray.com | |
| Manufactures X-ray systems and patient monitors for medical applications worldwide. | skanrayamericas.com |
Competitors & Alternatives of Skanray Technologies Limited
Brands and companies operating in the same space as Skanray Technologies Limited include GE Healthcare, Medtronic, Boston Scientific and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
GE Healthcare
|
Materials management solutions are provided for healthcare organizations. | Chicago, United States, United States | 1892 |
Medtronic
|
Medical equipment for treating over 30 chronic diseases is developed. | Minneapolis, United States, United States | 1949 |
Boston Scientific
|
Wide range of medical devices | Marlborough, United States, United States | 1979 |
Johnson & Johnson
|
Healthcare solutions are provided by Johnson & Johnson globally. | New Brunswick, United States, United States | 1886 |
Hologic
|
Diagnostic and surgical products for women's healthcare are provided. | Marlborough, United States, United States | 1985 |
CONMED
|
Surgical instruments are manufactured for multiple therapeutic areas. | Utica, United States, United States | 1987 |
Commure
|
Complex healthcare challenges are addressed through technology solutions by Commure. | San Francisco, United States, United States | 2016 |
Coherent
|
Laser-based and photonics products are manufactured for multiple applications. | Santa Clara, United States, United States | 1966 |
Baxter
|
Biosciences, medication delivery, and renal products are developed and marketed. | Deerfield, United States, United States | 1931 |
Danaher
|
Dental equipment and medical instruments are manufactured for therapeutic areas. | - | 1969 |
Business Activity of Skanray Technologies Limited
Skanray Technologies Limited is engaged in the principal business activity of manufacturing, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | ********* |
Board of Directors of Skanray Technologies Limited
Skanray Technologies Limited is currently managed by 6 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Doddaballapur Prasanna Achutarao
Also directs:
Acunova Life Sciences Llp, Mangalore Chemicals And Fertilisers Limited, Ajax Engineering Limited and 1 more
|
Director | 27 Mar 2021 | 5 Years 3 Months | Current |
|
Vishwaprasad Alva
Also directs:
Skanray Healthcare Partners Llp, Skancare Wellness Private Limited
|
Managing Director | 14 Feb 2007 | 19 Years 4 Months | Current |
| Reena Pandey | Director | 25 Mar 2021 | 5 Years 3 Months | Current |
| Jayashree Satagopan | Director | 12 May 2021 | 5 Years 1 Months | Current |
Financials of Skanray Technologies Limited FY 2025 filings available
Skanray Technologies Limited reported revenue of ₹213.3 Cr (down 22% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Skanray Technologies Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jan 2026 | State Bank of India | ₹20 Lakh | Open |
| 13 Nov 2024 | State Bank of India | ₹25 Lakh | Open |
| 06 Nov 2024 | State Bank of India | ₹114 Cr | Open |
| 18 Oct 2023 | Others | ₹16 Lakh | Open |
| 23 Aug 2023 | Others | ₹14 Lakh | Open |
Total charge records: 45 View all charges
Employees and EPFO Compliance at Skanray Technologies Limited
View historical data on people associated with Skanray Technologies Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Skanray Technologies Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Skanray Technologies Limited
GSTIN & GST Filing Data of Skanray Technologies Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Skanray Technologies Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Skanray Technologies Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Skanray Technologies Limited
MSME Payment Delays by Skanray Technologies Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Skanray Technologies Limited
Subsidiaries & Group Companies of Skanray Technologies Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Skanray Technologies Limited with ownership details.
MCA Filings & Documents of Skanray Technologies Limited
MCA Filings & Documents of Skanray Technologies Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Skanray Technologies Limited
Recent News on Skanray Technologies Limited
Frequently Asked Questions about Skanray Technologies Limited
Skanray Technologies Limited is an active public limited company in the healthcare sector based in Mysore, Karnataka, India. It was incorporated on 14 February 2007 (19+ years old) and is registered under CIN U72200KA2007PLC041774. The company has 626 employees.
Skanray Technologies Limited reported revenue of ₹213.3 Cr for FY 2025 (down 22.00% YoY).
The current directors of Skanray Technologies Limited are:
- Doddaballapur Prasanna Achutarao
- Vishwaprasad Alva
- Reena Pandey
- Jayashree Satagopan
- Lakshmi Dayanand Kamath
- Bhagya Gopalkrishna Mysore
The primary industry of Skanray Technologies Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Skanray Technologies Limited can be reached at the registered office: Plot No 15 – 17 Hebbal Industrial Area, Mysore, Karnataka, India – 570016, or through the website skanray.com.
The authorised capital is ₹50 Cr, and the paid-up capital is ₹44.11 Cr.